{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibpthx35um6z3auzgnpepjicqsnwzaxuui2cwxm3qucjlgdbv66p4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mpldmggjxom2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreid4hmzr7gu6z2uaskz23eg26wnncjas5iy6nsamtjurqasmqotmpm"
    },
    "mimeType": "image/jpeg",
    "size": 252646
  },
  "path": "/news/2026-06-glp-medications-linked-deaths-amputations.html",
  "publishedAt": "2026-07-01T05:00:11.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries associated with PAD (peripheral artery disease).",
  "title": "GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD"
}